Outlook Therapeutics OTLK
NASDAQ OTLK
$0.54 +0.02 (+4.61%)
As of: Oct 21, 2026 · 1:41 PM EDT

Outlook Therapeutics (OTLK) Finished Goods (2025 - 2026)

Updated

Outlook Therapeutics' Finished Goods was $184,939 in fiscal Q3 2026 (quarter ended Jun 30, 2026), down 51.0% from $377,223 a year earlier and down 8.4% from the prior quarter.

Analysis

Outlook Therapeutics (OTLK) Finished Goods (2025 - 2026) Analysis & Trends

At the end of FY2025 (ended Sep 30, 2025), Finished Goods at Outlook Therapeutics came in at $29,626.

  • Quarterly Finished Goods has moved between $29,626 (fiscal Q4 2025) and $3.33 million (fiscal Q2 2025) over five years.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,133.99 Bn 1,102.58 Bn 19.71 Bn
2 Johnson & Johnson 615.70 Bn 534.23 Bn 17.26 Bn
3 AbbVie 501.05 Bn 474.16 Bn 12.70 Bn
4 Merck 367.41 Bn 321.79 Bn 12.21 Bn
5 Novartis Ag 297.75 Bn 261.74 Bn 11.24 Bn
6 Astrazeneca 261.20 Bn 234.88 Bn 12.86 Bn
7 Amgen 235.55 Bn 190.95 Bn 7.24 Bn
8 Gilead Sciences 190.64 Bn 164.84 Bn 6.22 Bn
9 Pfizer 169.29 Bn 115.93 Bn 10.94 Bn
10 Outlook Therapeutics 74.53 Mn 38.77 Mn -8,265.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 184,939.00
Mar 31, 2026 201,903.00
Sep 30, 2025 29,626.00
Jun 30, 2025 377,223.00
Mar 31, 2025 3.33 Mn
API Access

Outlook Therapeutics Finished Goods API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=finished-goods&ticker=OTLK&period=max&api_key=YOUR_API_KEY